These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6312217)

  • 41. The application of molecular biology to the development of novel vaccines.
    Kniskern PJ; Hagopian A; Burke P; Dunn N; Montgomery DL; Schultz LD; Schulman CA; Carty CE; Maigetter RZ; Wampler DE
    Adv Exp Med Biol; 1989; 251():83-98. PubMed ID: 2532858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.
    Skinner GR; Buchan A; Williams D; Marsden J; Hartley C; Wilbanks G; Turyk M; Namkoong ES
    Br J Exp Pathol; 1982 Aug; 63(4):378-87. PubMed ID: 6295430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA sequence of the major capsid protein gene of herpes simplex virus type 1.
    Davison AJ; Scott JE
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2279-86. PubMed ID: 3020164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospects for new viral vaccines.
    Marmion BP
    Philos Trans R Soc Lond B Biol Sci; 1980 Aug; 290(1040):395-407. PubMed ID: 6106250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus.
    Massicot JG; Murphy BR; van Wyke K; Huang KY; Chanock RM
    Virology; 1980 Oct; 106(1):187-90. PubMed ID: 6893373
    [No Abstract]   [Full Text] [Related]  

  • 46. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. b. Herpes simplex virus].
    Kenichi U
    Nihon Rinsho; 1987 Oct; 45(10):2235-8. PubMed ID: 2834573
    [No Abstract]   [Full Text] [Related]  

  • 47. Genital herpes.
    Nilsen A
    Scand J Infect Dis Suppl; 1985; 47():51-7. PubMed ID: 3006234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral vaccines under development: a third generation.
    Osborn JE
    Adv Exp Med Biol; 1979; 118():61-82. PubMed ID: 227237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genital herpes.
    Oates JK
    Br J Hosp Med; 1983 Jan; 29(1):13-22. PubMed ID: 6297643
    [No Abstract]   [Full Text] [Related]  

  • 50. The hepatitis B virus.
    Tiollais P; Pourcel C; Dejean A
    Nature; 1985 Oct 10-16; 317(6037):489-95. PubMed ID: 2995835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of molecular genetics to the design of live herpes simplex virus vaccines.
    Roizman B; Warren J; Thuning CA; Fanshaw MS; Norrild B; Meignier B
    Dev Biol Stand; 1982; 52():287-304. PubMed ID: 6299836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression in bacteria of gB-glycoprotein-coding sequences of Herpes simplex virus type 2.
    Person S; Warner SC; Bzik DJ; Debroy C; Fox BA
    Gene; 1985; 35(3):279-87. PubMed ID: 2412940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant yeast hepatitis B vaccine.
    Hilleman MR
    Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
    [No Abstract]   [Full Text] [Related]  

  • 54. Gene constellation of live influenza A vaccines.
    Florent G
    Arch Virol; 1980; 64(2):171-3. PubMed ID: 7387405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine.
    Skinner GR; Fink CG; Cowan M; Buchan A; Fuller A; Hartley CE; Durham J; Wiblin C; Melling J
    Med Microbiol Immunol; 1987; 176(3):161-8. PubMed ID: 3037289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biology of hepatitis B virus.
    Tiollais P; Charnay P; Vyas GN
    Science; 1981 Jul; 213(4506):406-11. PubMed ID: 6264599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.
    Chelyapov NV; Antonova TP; Yanova NN; Chernos VI
    Acta Virol; 1988 Sep; 32(5):409-16. PubMed ID: 2904735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).
    Cox NJ; Kitame F; Kendal AP; Maassab HF; Naeve C
    Virology; 1988 Dec; 167(2):554-67. PubMed ID: 2974219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine].
    Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB
    Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Herpes simplex viruses: is a vaccine tenable?
    Whitley RJ; Roizman B
    J Clin Invest; 2002 Jul; 110(2):145-51. PubMed ID: 12122103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.